TCF7L2 and type 2 diabetes mellitus: TCF7L2 is a transcription factor involved in the Wnt-signaling pathway that has been suggested to be involved in almost 20% of T2D cases (86), and to increase risk of developing GDM by up to 1.9-fold (87) as well as to increase propensity toward weight gain (86).